Medicare Enrolled

Dr. Roman Kleynberg, M.D.

Hematology & Oncology · Los Angeles, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
6221 WILSHIRE BLVD, Los Angeles, CA 90048
3239655679
In practice since 2010 (15 years)
NPI: 1700103298 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kleynberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kleynberg? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kleynberg

Dr. Roman Kleynberg is a hematology & oncology specialist in Los Angeles, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Kleynberg performed 12,849 Medicare services across 4,663 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kleynberg received a total of $7,776 from 63 pharmaceutical and/or device companies across 356 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kleynberg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 27% volume in CA $7,776 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,849
Medicare services
Top 27% in CA for hematology & oncology
4,663
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~857 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
7,697 $66 $169
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
3,166 $100 $240
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
1,253 $109 $213
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
672 $146 $470
Remote video/image evaluation by established patient
A provider reviews recorded video or images submitted by an established patient and provides an interpretation with follow-up communication within 24 business hours.
61 $8 $30
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,776
Total received (2018-2024)
Avg $1,111/year across 7 years
Top 36% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
356
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,776 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$675
2023
$1,193
2022
$1,654
2021
$2,028
2020
$1,344
2019
$730
2018
$152

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$222
SOBI, INC
$47
PharmaEssentia USA Corporation
$47
Incyte Corporation
$43
PFIZER INC.
$37
JAZZ PHARMACEUTICALS INC.
$33
Ipsen Biopharmaceuticals, Inc
$30
E.R. Squibb & Sons, L.L.C.
$30
Janssen Pharmaceuticals, Inc
$27
Genmab U.S., Inc.
$26
TerSera Therapeutics LLC
$25
Gilead Sciences, Inc.
$24
Celgene Corporation
$23
Novartis Pharmaceuticals Corporation
$22
Bayer Healthcare Pharmaceuticals Inc.
$20
SpringWorks Therapeutics, Inc.
$19
Top 3 companies account for 46.8% of 2024 payments
All-time payments by company (2018-2024) ›
Incyte Corporation
$924
Janssen Biotech, Inc.
$744
Amgen Inc.
$729
PFIZER INC.
$591
Merck Sharp & Dohme Corporation
$381
E.R. Squibb & Sons, L.L.C.
$316
Novartis Pharmaceuticals Corporation
$280
Octapharma USA, Inc.
$262
GENZYME CORPORATION
$171
AstraZeneca Pharmaceuticals LP
$169
Karyopharm Therapeutics Inc.
$164
CTI BioPharma Corp.
$161
TerSera Therapeutics LLC
$156
Eisai Inc.
$146
Gilead Sciences, Inc.
$146
Bayer Healthcare Pharmaceuticals Inc.
$140
Bayer HealthCare Pharmaceuticals Inc.
$136
BIOTISSUE HOLDINGS, INC.
$136
Ipsen Biopharmaceuticals, Inc
$131
GlaxoSmithKline, LLC.
$126
Kite Pharma, Inc.
$123
PharmaEssentia USA Corporation
$111
PUMA BIOTECHNOLOGY, INC.
$80
Shionogi Inc
$78
JAZZ PHARMACEUTICALS INC.
$77
Genmab U.S., Inc.
$73
Lilly USA, LLC
$70
Dova Pharmaceuticals
$70
Takeda Pharmaceuticals U.S.A., Inc.
$69
Janssen Pharmaceuticals, Inc
$63
Global Blood Therapeutics, Inc.
$61
EISAI INC.
$59
ADC Therapeutics America, Inc.
$55
Abbott Laboratories
$51
SOBI, INC
$47
Mylan Institutional Inc.
$39
Merck Sharp & Dohme LLC
$38
Coherus Biosciences Inc.
$37
Genentech USA, Inc.
$37
Myriad Genetic Laboratories, Inc.
$37
Teva Pharmaceuticals USA, Inc.
$36
Sirtex Medical Inc
$35
EUSA Pharma (US) LLC
$29
Puma Biotechnology, Inc.
$29
Jazz Pharmaceuticals Inc.
$24
Daiichi Sankyo Inc.
$24
Celgene Corporation
$23
Chiesi USA, Inc.
$23
Taiho Oncology, Inc.
$22
GE HEALTHCARE
$21
Seattle Genetics, Inc.
$21
Progenics Pharmaceuticals, Inc.
$21
Organon LLC
$20
Spectrum Pharmaceuticals Inc.
$19
SpringWorks Therapeutics, Inc.
$19
Sobi, Inc
$18
Seagen Inc.
$18
Mirati Therapeutics, Inc.
$16
Dendreon Pharmaceuticals LLC
$16
ARRAY BIOPHARMA INC
$15
Alnylam Pharmaceuticals Inc.
$15
Emmaus Medical, Inc.
$14
Acrotech Biopharma LLC
$14
Top 3 companies account for 30.8% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALUNBRIG · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · Blincyto · CABLIVI · CALQUENCE · CARVYKTI · CYRAMZA · Confirm Rx · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · Endari · Enhertu · Epkinly · FERRIPROX · Fabhalta · Fulphila · GAMIFANT · GIVLAARI · HEMADY · IBRANCE · ICLUSIG · IMBRUVICA · INLYTA · JAKAFI · JEMPERLI · KEYTRUDA · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MONJUVI · MYCHOICE CDX · Mulpleta · NEOX · NERLYNX · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · ONTRUZANT · OPDIVO · OXBRYTA · Ogivri · Onivyde · PANZYGA · PEMAZYRE · PIQRAY · PROMACTA · PROVENGE · PYLARIFY · Quzyttir · REBLOZYL · ROLVEDON · RYBREVANT · SARCLISA · SIR-Spheres Microspheres · SOMATULINE DEPOT · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · Trodelvy · Udenyca · VONJO · VYXEOS · Vectibix · Vonjo · XARELTO · XPOVIO · Xermelo · ZEJULA · ZEPZELCA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Los Angeles?
Compare hematology & oncology specialists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
395
Per 100K population
4.0
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kleynberg is a mixed practice specialist, with above-average Medicare volume (top 27% in CA), with low-engagement industry engagement, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kleynberg experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Kleynberg performed 7,697 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kleynberg receive payments from pharmaceutical companies?
Yes. Dr. Kleynberg received a total of $7,776 from 63 companies across 356 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kleynberg's costs compare to other hematology & oncology specialists in Los Angeles?
Dr. Kleynberg's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kleynberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →